Feluda-The New Low Cost Covid 19 Test by TATA CRISPR. The Drugs Controller General of India (DCGI) has approved the commercial launch of ‘Feluda’, the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of Scientific and Industrial Research (CSIR) said on 19 Sep 2020. This test uses an indigenously...

India’s GDP Crashed: Act of God or Act of Fraud? It is not long ago that we talked about a double-digit growth and our economy used to be the fastest-growing major economy in the world and today, we stand at a point where our growth has sunk to around minus 24% (minus 23.9% to be exact).   Here, we will talk about why that happened, but...